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Abstract
Background: Several studies have observed an inverse relationship between osteoporosis and spinal osteoarthritis,
the latter being considered as possibly delaying the development of osteoporosis. The aim of this study was to
determine the association between individual radiographic features of spine degeneration, bone mineral density
(BMD) and bone-turn over markers.
Methods: It was a cross sectional study of 277 post menopausal women. BMD of all patients was assessed at the
spine and hip using dual-energy X-ray absorptiometry. Lateral spinal radiographs were evaluated for features of
disc degeneration. Each vertebral level from L1/2 to L4/5 was assessed for the presence and severity of
osteophytes and disc space narrowing (DSN). For Bone turn-over markers, we assessed serum osteocalcin and
C-terminal cross-linking telopeptide of type I collagen (CTX). Linear regressions and partial correlation were used
respectively to determine the association between each of disc degeneration features, BMD, and both CTX and
osteocalcin.
Results: Mean age of patients was 58.7 ± 7.7 years. Eighty four patients (31.2%) were osteoporotic and 88.44% had
spine osteoarthritis. At all measured sites, there was an increase in BMD with increasing severity of disc narrowing
while there was no association between severity of osteophytes and BMD. After adjustment for age and BMI, there
was a significant negative correlation between CTX and DSN. However, no significant correlation was found
between CTX and osteophytes and between osteocalcin and both osteophytes or DSN.
Conclusion: In post menopausal women the severity of disc narrowing, but not osteophytes, is associated with a
generalized increase in BMD and a decreased rate of bone resorption. These results are consistent with the
hypothesis that osteoarthritis, through DSN, has a protective effect against bone loss, mediated by a lower rate of
bone resorption. However, spine BMD is not a relevant surrogate marker for the assessment of osteoporosis in the
spine in patients with osteoarthritis and debate as to the relationship between OA and OP is still open because of
the contradictory data in the literature.
Background
Osteoporosis (OP) and osteoarthritis (OA) are two com-
mon age-related skeletal disorders responsible for major
health expenses in the elderly. While OA is a joint dis-
ease characterized by degeneration of articular cartilage
and bone remodeling that may affect different sites and
involve peripheral or axial joints, OP is characterized by
low bone mass, and microarchitectural deterioration of
bony tissue, with a consequent increase in bone fragility
and susceptibility to fractures. According to the WHO
criteria, osteoporosis can also be defined as a value of
bone mineral density (BMD) more than 2.5 standard
deviations below the young normal mean.
It would be anticipated that osteoporosis and osteoar-
thritis frequently coexist due to their high prevalence in
elderly women but the association between these
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any medium, provided the original work is properly cited.conditions is still controversial [1,2] even after years of
research since the first results indicate an apparent
inverse relationship [3,4]. Indeed, many studies have
shown an association between high bone mineral density
at the spine and hip and OA of the hips, knees or hands
[5-8]. However, there are conflicting findings in the few
published studies on the association between bone mass
and degenerative disease in the spine, the latter being
characterized by disc space narrowing (DSN) and the
presence of vertebral osteophytes. Most [9-13], though
not all [14-16] studies that examined the association
between osteophytes and bone mass at the spine and
distant sites including the hip, suggest that they are
linked to an increased bone mass. Results are also dis-
cordant about the association between DSN and BMD
at distant sites. In a population of patients with OA of
the hip, isolated DSN without osteophytes was not asso-
ciated with high bone mass [17]. In contrast, in a gen-
eral population, those with isolated DSN have a higher
BMD in the spine (but not in the hip) than those with-
out [9].
In order to understand the underlying mechanism of
the interaction between bone mass and OA, noninvasive
biochemical assays for markers of bone resorption
(which the CTX-I is the most specific and sensitive
one), and bone formation have been developed and
enabled estimation of bone turnover. Few studies of bio-
chemical markers have been reported in subjects with
spinal OA, results have also been conflictual [18-20].
We undertook this study to determine the association
between radiographic features of lumbar disc degenera-
tion, namely osteophytes and DSN, and BMD at differ-
ent measured sites, as well as to investigate the
underlying mechanism at the tissue level through assess-
ment of biochemical markers of bone metabolism.
Methods
Subjects
The study involved 277 consecutive ambulatory post-
menopausal women living in urban centre of Morocco
and sent to our outpatient Bone Densitometry Center.
Recruitment was based on voluntary enrolment. Writ-
ten informed consent was obtained from all subjects
and the study was approved by the Ethical Committee
of El Ayachi University Hospital of Rabat-Sale. We
excluded from the study all patients with a history of:
(1) taking drugs known to influence bone metabolism
in the past two years, such as vitamin D, calcium, cor-
ticosteroids, bisphosphonates, sodium fluoride, raloxi-
fene, strontium ranelate, teriparatide and hormone
replacement therapy; (2) musclo skeletal, thyroid, para-
thyroid, adrenal, hepatic, or renal disease; (3) malig-
nancy; and (4) hysterectomy.
Data collection and measurements
Each patient completed a questionnaire on sociodemo-
graphic parameters and osteoporosis risk factors such as
female sex, age higher than 60 years, family history of
osteoporosis, early menopause, low BMI, smoking,
sedentary lifestyle, long term (≥3 months) corticosteroid
use and excessive alcohol consumption. Weight and
height were measured without clothes or shoes at the
time of bone densitometry measurements. The body
mass index (BMI) was calculated as body weight divided
by height squared (Kg/m
2).
Bone mineral density (BMD) measurements
Lumbar spine, trochanter, femoral neck and total hip
BMD were measured by dual-energy X-ray absorptiome-
try with a Lunar prodigy densitometer. Only vertebras
with scoliosis have been excluded from BMD test. Daily
quality control was carried out by measurement of a
Lunar phantom. At the time of the study, phantom
measurements showed stable results. The in vivo preci-
sion error for dual-energy X ray absorptiometry,
expressed as coefficient of variation, was 0.9% at the
lumbar spine and 1% at the femoral neck. Both T and Z
scores were obtained. In the T-score calculations, the
manufacturer’s ranges for European reference popula-
tion were used because of the absence of a Moroccan
data base.
Assessment of lumbar spine degeneration
Lumbar spine radiographs were taken according to a
standard protocol with the film centred at L2 (Figure 1).
The radiographs were subsequently evaluated by a single
observer for the presence of the individual radiographic
features of disc degeneration. Each vertebral level from
L1/2 to L4/5 was assessed for the presence and severity
of osteophytes and DSN, using a semiquantitative score
(grade 0, none; grade 1, mild; grade 2, moderate; grade 3,
severe) [21]. We defined, for each radiographic feature,
two summary statistics: ‘’MAX’’, which was the grade of
the most severely affected vertebral level per subject
(from L1/2 to L4/5) and which could range from 0 to 3,
and ‘’SUM’’, the sum of the four vertebral specific grades
per subject which thus could range from 0 to 12.
Biochemical measurements
Morning fasting blood was collected from every subject for
the measurement of the following parameters: osteocalcin
and C-terminal cross-linking telopeptide of type I (CTX).
Both parameters were measured by immunochemolumi-
nometric assay (Elecsys, Roche diagnostics, Mannheim,
Germany). Intra- and interassay variances were 5% and
7%, and the normal range were 15-46 ng/ml for osteocal-
cin, and 0.3-0.6 ng/ml for CTX.
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Statistical analysis was performed with SPSS for Win-
dows 13.0 (SPSS Inc., Chicago, IL, USA). Population
descriptions are expressed as mean ± standard deviation
(SD) for continuous variables and as percentage distri-
butions for discrete variables.
Linear regression was used to determine the associa-
tion between each of the two radiographic features
(using both MAX and SUM) and BMD (dependent vari-
able) at spine and femoral sites. Adjustments were made
for age and BMI. We examined MAX as a continuous
variable to test for any trend of increasing bone mass
with increasing grade of radiographic feature. We exam-
ined SUM as a continuous variable to test for any trend
of increasing bone mass with increasing grade of feature
with the results expressed as b coefficients and 95%
confidence intervals.
Partial correlation after adjusting for age and BMI was
performed to determine the strength of the association
between each of the radiographic features (using both
MAX and SUM) and CTX and Osteocalcin. p values
lower than 0.05 were considered as statistically
significant.
Results
Clinical characteristics
Characteristics of participants enrolled in this cross sec-
tional study are shown in table 1. Mean age and BMI
were 58.7 ± 7.7 years and 29.08 ± 4.35 kg/m
2 respec-
tively. 123 women (44.4%) had overweight (BMI > 25)
and 101 (36.5%) were obese. 88.44% of the 277 included
in the study had spine osteoarthritis and 31.2% were
osteoporotic. 43.5% had osteopenia, 46.6% of them had
at least a prevalent vertebral fracture and 12.3% had a
history of low trauma peripheral fractures. The preva-
lence of osteophytes and lumbar DSN was 87.5% and
47.2% respectively. Most of the patients (78.8%) had a
grade 1 of osteophytes. For DSN, 37.8%, 7.2% and 2.2%
of the patients had a grade 1, 2 and 3 respectively.
Mean level of CTX I and osteocalcin was 0.49 ± 0.25
and 24.56 ± 13.56 respectively.
Maximum grade of radiographic feature (MAX) and BMD
✓ Lumbar spine BMD
The association between BMD at the lumbar spine and
the maximum grade of each radiographic feature per
subject (MAX) is shown in table 2. After adjusting for
age and BMI, lumbar spine BMD increased with
Figure 1 Osteophytosis and DSN demonstrated on a lateral
lumbar spine X-ray. Table 1 Subject characteristics
Variable All subjects (N = 277)
Mean ± SD
Age (years) 58.7 ± 7.7
Age of menopause (years) 47.30 ± 5.28
Weight (kg) 71.38 ± 11.60
Height (m) 1,56 ± 0,06
BMI (Kg/m
2) 29.08 ± 4.35
Lumbar spine BMD (g/cm
2) 0.966 ± 0.159
Femoral neck BMD (g/cm
2) 0.848 ± 0.130
Femoral trochanter BMD (g/cm
2) 0.693 ± 0.120
Total femoral BMD (g/cm
2) 0.892 ± 0.134
CTX I 0.49 ± 0.25
Osteocalcin 24.56 ± 13.65
n%
Prevalence of osteoporosis 84 31,2
Prevalence of spine osteoarthritis 245 88.44
BMD: bone mineral density
BMI: body mass index
DSN: disc space narrowing
CTX: C-terminal cross-linking telopeptide of type I collagen
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the mean age-adjusted lumbar spine BMD rises from
0.95 g/cm
2 for patients without DSN to 1.118 g/cm
2 for
patients with grade 3 of DSN (p = 0.001). This trend of
increasing BMD with increasing grade of DSN persisted
after adjusting for BMI. However, there was no associa-
tion between lumbar spine BMD and osteophytes.
✓ Femoral BMD
The association between the MAX of each radiographic
features and BMD at the neck, tochanter, and total
femoral is shown in table 2. After adjusting for age,
patients with grade 2 of DSN had an increased BMD at
all measured sites than other patients. For example, the
mean age-adjusted femoral neck BMD was 0.845 g/cm
2
for patients without DSN and 0.870 g/cm
2 for patients
with grade 2 of DSN (p = 0.003). This trend of increas-
ing BMD in patients with grade 2 of DSN persisted after
adjusting for BMI. In contrast, there was no association
between femoral BMD and osteophytes.
Summary score for radiographic features (SUM) and BMD
The influence of the radiographic features as assessed
using the total score (SUM) across all the four interverteb-
ral levels, on BMD at all measured sites, is shown in table
3. Results are expressed as b coefficients which may be
interpreted as the absolute change in BMD (g/cm
2)p e r
unit change in score. BMD at all measured sites increased
with SUM DSN. For example, after age adjustment, lum-
bar BMD increased by a value of 0.02 g/cm
2 for each unit
change in the total DSN score. The observed associations
remain unchanged after adjustment for age and BMI.
However, there was no association between BMD at all
measured sites and SUM osteophytes.
Relationship between osteoarthritis and bone turn over
markers
A significant decrease in CTX-I levels associated with
lumbar spine disc degeneration was observed (table 4).
Indeed, after adjustment for age and BMI there was a
significant negative correlation between CTX and MAX
DSN (r adjusted = -0.192, p = 0. 026). The level of CTX
was also negatively associated with SUM DSN (r
adjusted = -0.209, p = 0.019). However, no significant
correlation was found between CTX and MAX or SUM
osteophytes and between osteocalcin; and both SUM
and MAX DSN or osteophytes.
Discussion
Our data show that in post menopausal women increas-
ing severity of disc space narrowing, but not osteo-
phytes, is related to increasing bone mineral density at
all measured sites. The severity of disc space narrowing
Table 2 Maximum grade (MAX) of individual radiographic features and BMD at different measured sites in 277
postmenopausal women
Lumbar spine BMD Trochanter BMD Femoral neck BMD Femoral total BMD
n (%) Mean
(SD)
Multivariate
analysis b (95%
CI)
Mean
(SD)
Multivariate
analysis b (95%
CI)
Mean
(SD)
Multivariate
analysis b (95%
CI)
Mean
(SD)
Multivariate
analysis b (95%
CI)
Osteophytes
Grade 0 34 (12.5) 0.983
(0.187)
1 0.710
(0.125)
1 0.884
(0.125)
1 0.925
(0.149)
1
Grade 1 219 (78.8) 0.963
(0.153)
-0.01 (-0.05 to 0.05) 0.693
(0.121)
-0.01 (-0.04 to 0.03) 0.845
(0.134)
-0.02 (-0.07 to 0.02) 0.889
(0.132)
-0.01 (-0.01 to 0.02)
Grade 2 11 (4.0) 0.937
(0.217)
0.02 (-0.07 to 0.13) 0.643
(0.103)
-0.01 (-0.08 to 0.06) 0.822
(0.884)
-0.01 (-0.08 to 0.08) 0.849
(0.110)
0.01 (-0.07 to 0.08)
Grade 3 13 (4.7) 0.989
(0.140)
-0.01 (-0.08 to 0.06) 0.693
(0.120)
-0.01 (-0.08 to 0.06) 0.831
(0.992)
-0.03 (-0.11 to 0.04) 0.891
(0.128)
-0.01 (-0.08 to 0.06)
DSN
Grade 0 146 (52.8) 0.953
(0.156)
1 0.686
(0.121)
1 0.845
(0.144)
1 0.896
(0.137)
1
Grade 1 105 (37.8) 0.974
(0.255)
0.02 (-0.01 to 0.06) 0.674
(0.114)
0.01 (-0.01 to 0.04) 0.849
(0.110)
0.01 (-0.02 to 0.04) 0.885
(0.130)
-0.01 (-0.03 to 0.02)
Grade 2 20 (7.2) 0.966
(0.232)
0.07 (-0.01 to 0.14)* 0.689
(0.152)
0.05 (-0.01 to 0.10)* 0.870
(0.137)
0.08 (0.02 to 0.14)* 0.893
(0.146)
0.06 (0.01 to 0.12)*
Grade 3 6 (2.2) 1.118
(0.861)
0.19 (0.07 to 0.30)* 0.683
(0.120)
0.01 (-0.06 to 0.10) 0.843
(0.931)
0.02 (-0.07 to 0.12) 0.909
(0.107)
0.05 (-0.04 to 0.14)
*p < 0.05
Adjustment for age and BMI in the multivariate analysis
BMD: bone mineral density
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without any effect on bone formation.
Marked differences in the prevalence of spinal degen-
eration features occur in association with older age,
female sex, post menopausal women and obesity. In our
study, the prevalence of spine osteoarthritis was high
(88.44%). 78.7% and 47.7% of patients had at least one
osteophyte or at least one DSN respectively. This can be
explained by age (Mean (SD) age was 58.7 ± 7.7), sex,
overweight (44.4% had BMI > 25) and obesity (36.5% of
the patients). Mean (SD) BMI was 29.08 ± 4.35.
On the other hand, several studies observe an inverse
relationship between OP and spine OA, the latter being
considered as possibly delaying the development of OP
[10,18,19,21]. Our data showed that increasing BMD in
spine OA is more related to DSN than to osteophytes.
Indeed, after adjusting for age and BMI, no association
was found between BMD at all measured sites and the
severity of osteophytes. This can be explained by the
fact that the majority of the patients (78.8%) had only a
grade 1 of osteophytes which corresponds to a mild
involvement of this radiographic feature. The influence
of osteophytes on BMD has been the focus of various
studies, which showed, in contrast to our findings
[6,10,12,16-18], that spinal BMD was greater in verteb-
rae with osteophytes. Several other studies have exam-
ined the association between osteophytes and bone mass
at distant sites including the hip and most [6,9-13,18],
though not all [14-16] suggest that they are also linked
to an increased bone mass. However, it is important to
note that spine disc degeneration can hinder the inter-
pretation of spine BMD: osteophytes cannot be distin-
guished from vertebral bone mineral using BMD area
measurements and may even in some cases overestimate
the measurements of bone mass in the affected areas.
Therefore, it has been suggested that spine BMD is not
a relevant surrogate marker for the assessment of osteo-
porosis in the spine in patients with osteoarthritis [9,12].
Relatively little however is known about the associa-
tion between bone mass and DSN and there are also
conflicting findings in the few published studies on the
subject [12-14,16,17]. Thus, in a population of patients
with OA of the hip, isolated DSN without osteophytes
was not associated with high bone mass [17]. In con-
trast, Pye et al showed an association between DSN and
increasing BMD at the spine but not at the hip [9]. Our
data show that increasing severity of DSN is associated
with increasing BMD at all measured sites and support,
through the DSN results, the hypothesis that degenera-
tive disc disease is inversely linked with osteoporosis.
The mechanism is unknown though several are possi-
ble; including confounding by environmental or constitu-
tional factors, hormonal, metabolic, and genetic factors
[22,23]. Our results remained unchanged after adjust-
ment for age and BMI, suggesting that they do not play a
major role in explaining the observed associations.
Few studies of biochemical markers have been
reported in subjects with spinal OA, with discordant
results [18-20]. Peel et al [18] and El Miedany et al [19]
have shown that spinal OA is associated with a general-
ized increase in BMD and decreased levels of serum and
urinary biochemical markers of bone formation and
bone resorption in patients with spine disc degeneration.
It has been suggested that the protective effect of spinal
OA against OP may be mediated through decreased rate
of bone turnover. Garnero et al [20] in a large cohort of
untreated postmenopausal women participating in the
OFELY prospective study have shown recently that lum-
bar spine DSN, but not osteophytes, is strongly asso-
ciated with increased CTX-II degradation, independently
of age and BMI. Our results agree partially with what
has been reported by Peel et al. and El Miedany et al
[18,19] who found in their studies a decrease in bone
Table 3 Total scores (SUM) of individual radiographic features and BMD at different measured sites, after adjusting
for age and BMI, in 277 postmenopausal women
Lumb spine BMD
b (95% CI)
Trochanter BMD
b (95% CI)
Femoral neck BMD
b (95% CI)
Total femoral BMD
b (95% CI)
Osteophyte -0.01 (-0.01 to 0.01) -0.01 (-0.01 to 0.01) -0.01 (-0.01 to 0.01) -0.01 (-0.01 to 0.01)
DSN 0.02 (0.01 to 0.03)* 0.01 (0.01 to 0.02)* 0.01 (0.01 to 0.02)* 0.01 (0.01 to 0.02)*
*p < 0.05
BMD: bone mineral density
DSN: disc space narrowing
CI: confidence interval
Table 4 Partial Correlation showing a significant negative
correlation between CTX and DSN in 277
postmenopausal women
CTX r adjusted Osteocalcin r adjusted
MAX osteophyte -0.097 -0.032
SUM osteophyte -0.137 -0.135
MAX DSN -0.192* -0.036
SUM DSN -0.209* -0.075
*p < 0.05
Adjustement for age and BMI
CTX: C-terminal cross-linking telopeptide of type I collagen
DSN: disc space narrowing
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we did not find any effect of spine disc degeneration on
bone formation. Moreover, no association was found
between the severity of osteophytes and either increas-
ing BMD or CTX levels.
Our study is limited by its cross-sectional design and
t h eu s eo fas e m i q u a n t i t a t i v es c o r et oc l a s s i f yt h er a d i o -
graphic features of disc degeneration. As with any subjec-
tive evaluation, this is subject to errors of interpretation
which may result in misclassification. However, this
defect applies to all studies in this field because the same
grading systems are used universally. Moreover, only
9.4% of our subjects had disc space narrowing that was
associated with a significantly increased bone mineral
density and further studies on a larger population are
necessary to confirm our findings. Finally, and as men-
tioned above, spine BMD is not a relevant surrogate mar-
ker for the assessment of osteoporosis in the spine in
patients with osteoarthritis. Indeed, measurements of
BMD taken by DXA are the most accurate procedure for
the diagnosis of osteoporosis nowadays. However, these
measurements are two-dimensional and when made with
an anterior-posterior projection, the most used incidence,
this procedure has the disadvantage of measuring the
density of all the mineral components encountered in the
X-ray pathway, including osteophytes, bone sclerosis,
disk space narrowing, spondylolisthesis, vertebral frac-
tures, and vascular and extra-vertebral calcifications.
Moreover, some studies has actually shown that obesity
and these alterations can influence bone mineral density
results. Although this defect applies to all studies in this
field because DXA is used universally, it would be inter-
esting to study OA in other places.
Conclusion
This study showed that in post menopausal women the
severity of disc narrowing, but not osteophytes, was
associated with a generalized increase in BMD and a
decreased rate of bone resorption. These results are
consistent with the hypothesis that osteoarthritis,
through disc space narrowing, has a protective effect
against bone loss, mediated by a lower rate of bone
resorption. However, spine BMD is not a relevant surro-
gate marker for the assessment of osteoporosis in the
spine in patients with osteoarthritis and debate as to the
relationship between OA and OP is still open because of
the contradictory data in the literature.
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